24/7 Clients Support
| Brand Name | ACALIEVA 100MG |
| Composition | Acalabrutinib Capsules 100mg |
| Manufacture By | Allieva Pharma Private Limited |
| Form | Capsule |
| Packing | Btl (30 cap) |
| Country Of Origin | India |
| Description | ACALIEVA contains Acalabrutinib, a second-generation Bruton’s Tyrosine Kinase (BTK) inhibitor. It works by blocking BTK signaling in B-cells, thereby inhibiting the growth and survival of malignant B-lymphocytes. |
| Uses | Acalabrutinib is indicated for the treatment of: 1. Chronic Lymphocytic Leukemia (CLL) 2. Small Lymphocytic Lymphoma (SLL) 3. Mantle Cell Lymphoma (MCL) – in patients who have received at least one prior therapy |
| Side Effects | Common side effects: • Headache • Diarrhea • Fatigue • Muscle pain • Upper respiratory tract infections Hematological: • Anemia • Neutropenia • Thrombocytopenia Serious side effects: • Bleeding events • Atrial fibrillation • Severe infections |
| Dosage | • Standard dose: 100 mg orally twice daily • Swallow capsules whole with water • Can be taken with or without food • Avoid proton pump inhibitors; separate dosing from antacids or H2 blockers |